Arrowhead Pharmaceuticals, Inc. (ARWR)

70.16 +0.33 (+0.47%) USD  |  NASDAQ  |  Dec 24, 12:59
70.09 -0.07 (-0.10%) After-Hours: 13:59
More

Arrowhead Pharmaceuticals SG&A Expense (TTM): 123.94M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. 527.29M
Ionis Pharmaceuticals, Inc. 351.68M
Alnylam Pharmaceuticals, Inc. 1.181B
Amgen, Inc. 6.976B
Pfizer Inc. 13.91B